Asterasys Co (XKRX:450950) ROCE %: 3.82% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:450950 Asterasys Co Ltd XKRX:450950
23 GF Score
Price ₩5,130.00
! 4 Warning Signs
View Full Analysis

What is Asterasys Co ROCE %?

Asterasys Co XKRX:450950 -4.29% 23 ROCE % is 3.82% as of Jun. 2026. GuruFocus rates XKRX:450950 with a GF Score™ of 23/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Asterasys Co's annualized ROCE % for the quarter that ended in Jun. 2026 was 3.82%.

Asterasys Co  (XKRX:450950) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Asterasys Co ROCE % Related Terms

Asterasys Co ROCE % Historical Data

* Premium members only.

The historical data trend for Asterasys Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asterasys Co ROCE % Chart

Asterasys Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
71.95 39.07 24.61 50.69 32.47

Asterasys Co Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.87 26.08 36.46 -8.28 3.82
XKRX:450950
23GF Score
Asterasys Co Ltd XKRX:450950
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asterasys Co ROCE % Calculation

Asterasys Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=10852.487/( ( (24728.775 - 4829.339) + (52211.905 - 5264.426) )/ 2 )
=10852.487/( (19899.436+46947.479)/ 2 )
=10852.487/33423.4575
=32.47 %

Asterasys Co's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=1721.416/( ( (52214.445 - 7790.558) + (51049.594 - 5342.429) )/ 2 )
=1721.416/( ( 44423.887 + 45707.165 )/ 2 )
=1721.416/45065.526
=3.82 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.82% mean?
Asterasys Co (XKRX:450950) has a ROCE % of 3.82% as of Jun. 2026.
Is Asterasys Co's ROCE % too high?
Asterasys Co's current ROCE % is 3.82%. The Medical Devices & Instruments industry median ROCE % is 2.99. Asterasys Co's value of 3.82% is 27.8% above this industry median. Overall, Asterasys Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Asterasys Co's ROCE % compare to ABT and SYK?
Asterasys Co's ROCE % of 3.82% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.99. Asterasys Co's value of 3.82% is 27.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.99, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asterasys Co's current ROCE % of 3.82% is 27.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asterasys Co's current ROCE % is 3.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asterasys Co stock overvalued right now?
Asterasys Co (XKRX:450950) has a current ROCE % of 3.82%. The current ROCE % is 3.82% and 27.8% above the Medical Devices & Instruments industry median of 2.99. Asterasys Co's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Asterasys Co (XKRX:450950), the current ROCE % is 3.82% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asterasys Co Business Description

Address 66, Seongsui-ro, 12th Floor, Seongdong-gu, Seoul, KOR
Asterasys Co Ltd is a professional healthcare and biomedical corporation based in Korea. It is engaged in the Manufacture of electro-diagnostic and electro-therapeutic apparatuses featuring body composition analyzers such as the InBalance series and HIFU systems such as the Liftera series, it provides total solutions with healthcare, skincare, and IoT-oriented services that can connect with its product portfolio.
23GF Score

Get the complete analysis for XKRX:450950

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩5,130.00
Price